Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease

Journal of Pediatrics

Volumn 140, Issue 5, 2002, Pages 595-599

  Gill, Joan Cox ^a,b   Ottum, Marilyn ^a,b   Schwartz, Bruce ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Aventis Behring   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; PROCOAGULANT; RISTOCETIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; FLUID INTAKE; FLUSHING; HEADACHE; HEMOPHILIA A; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS; VON WILLEBRAND DISEASE;

EID: 0036082743     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.123626     Document Type: Article

References (20)

1. Hemophilia 1996
2. Hemophilia A
3. Therapy of factor VIII deficiency
4. Treatment of von Willebrand's disease
5. Current management of von Willebrand's disease
6. Rational intervention in von Willebrand disease
7. Response to 1-deamino-8D-arginine vasopressin in von Willebrand disease
8. Intranasal DDAVP: Biological and clinical evaluation in mild factor VIII deficiency
9. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I
10. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease
11. Nasal spray desmopressin (DDAVP)-Experience in-home care and surgical prophylaxis
12. High-dose intranasal desmopressin (DDAVP) in the management of women with menorrhagia and von Willebrand's disease
13. Screening and diagnosis of coagulation disorders
14. Osmoregulation and desmopressin pharmacokinetics in enuretic children
15. Clinical perspectives in primary nocturnal enuresis
16. Management of nocturnal enuresis in children with desmopressin and bladder physiotherapy
17. Hyponatremia in patients with nocturnal enuresis treated with DDAVP
18. Treatment with oral desmopressin in adolescents with primary nocturnal enuresis: Efficacy and long-term effect
19. Hyponatremia and seizures in young children given DDAVP